Hologenix formed the Science Advisory Board in 2011 to further establish itself as the leader in responsive textile technologies. Hologenix works in partnership with the SAB to identify, design and execute rigorous clinical studies to further validate and substantiate our significant claims. The appointments include Dr. Michael Hamblin (Photobiology), Dr. Shimon Weiss (Nanotechnology), Dr. Christopher Drake (Sleep Medicine), and Dr. Lawrence Lavery (Diabetes and Wound Care).
Dr. Hamblin (Photobiology)– With over 30 years of experience, Dr. Hamblin is the
Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital and is an Associate Professor of Dermatology at Harvard Medical School. He is also a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. For the past seven years, Dr. Hamblin has chaired an annual conference at SPIE Photonics West entitled “Mechanisms for Low-Light Therapy.”
Dr. Weiss (Nanotechnology)– Dean M. Willard Chair in Chemistry and Professor of Chemistry and Biochemistry, Physical Chemistry, and Physiology and a member of the California NanoSystems Institute at UCLA. He has been a scientific researcher for over 20 years, both in and out of the university. The Weiss lab has worked on ultrasensitive single molecule spectroscopy methods for over 15 years, and was the first to introduce the single molecule FRET method and were among the first to
introduce quantum dots to biological imaging.
Dr. Drake (Sleep Medicine)– Chairman of the National Sleep Foundation, Bioscientific Staff Investigator at the Henry Ford Hospital Sleep Disorders Research Center, in addition to being associate Professor of Psychiatry and Behavioral Neurosciences at the School of Medicine, Wayne State University. Along with authoring over 150 articles, reviews and abstract in his field, Dr. Drake serves on the editorial board of various sleep behavioral sleep field journal.
Dr. Lavery (Diabetes and Wound Care)– Currently a professor of surgery at
University of Texas Southwestern Medical Center, Dr. Lavery is also the Vice Chair of Medical Affairs, Chronic Disease Specialists. He has served on the editorial board for Diabetes Care and has been published in more than 140 peer-reviewed publications. He is also the former chair of the American Diabetes Association Foot Care Council.
For more information on our science advisory board, please contact us: